Clinical Cancer Research, Vol 3, Issue 6 837-847, Copyright © 1997 by American Association for Cancer Research

ARTICLES

O6-benzylguanine and its role in chemotherapy

ME Dolan and AE Pegg
Department of Medicine, Committees on Clinical Pharmacology and Cancer Biology, University of Chicago, Chicago, Illinois 60637, USA.

The presence of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase (AGT) in tumor cells is a significant source of resistance to chemotherapeutic alkylnitrosoureas and alkyltriazenes. O6-Benzylguanine provides a means to effectively inactivate the AGT protein and increase the chemotherapeutic effectiveness of chloroethylating and methylating agents in vitro and in human tumor xenograft models. Phase I clinical trials of the combination of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea are ongoing. Efforts directed at overcoming potential enhanced hematopoietic toxicity and mutagenicity have included the use of gene therapy to express an alkyltransferase gene in the relevant marrow stem cells. Altered AGT proteins resistant to O6-benzylguanine generated from point mutations in the mammalian alkyltransferase gene have been expressed in animal models using retroviral transduction techniques. It is anticipated that the successful application of this approach in humans may provide a means to increase the therapeutic index of O6-benzylguanine and 1, 3-bis(2-chloroethyl)-1-nitrosourea.

This article has been cited by other articles:

				J. N. Sarkaria, G. J. Kitange, C. D. James, R. Plummer, H. Calvert, M. Weller, and W. Wick Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma Clin. Cancer Res., May 15, 2008; 14(10): 2900 - 2908. [Abstract] [Full Text] [PDF]

				S. K. Niture, C. S. Velu, Q. R. Smith, G.J. Bhat, and K. S. Srivenugopal Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines Carcinogenesis, February 1, 2007; 28(2): 378 - 389. [Abstract] [Full Text] [PDF]

				M. Ranson, M. R. Middleton, J. Bridgewater, S. M. Lee, M. Dawson, D. Jowle, G. Halbert, S. Waller, H. McGrath, L. Gumbrell, et al. Lomeguatrib, a Potent Inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors Clin. Cancer Res., March 1, 2006; 12(5): 1577 - 1584. [Abstract] [Full Text] [PDF]

				T. F. Gajewski, J. Sosman, S. L. Gerson, L. Liu, E. Dolan, S. Lin, and E. E. Vokes Phase II Trial of the O6-Alkylguanine DNA Alkyltransferase Inhibitor O6-Benzylguanine and 1,3-Bis(2-Chloroethyl)-1-Nitrosourea in Advanced Melanoma Clin. Cancer Res., November 1, 2005; 11(21): 7861 - 7865. [Abstract] [Full Text] [PDF]

				L. H. Jensen, A. V. Thougaard, M. Grauslund, B. Sokilde, E. V. Carstensen, H. K. Dvinge, D. A. Scudiero, P. B. Jensen, R. H. Shoemaker, and M. Sehested Substituted Purine Analogues Define a Novel Structural Class of Catalytic Topoisomerase II Inhibitors Cancer Res., August 15, 2005; 65(16): 7470 - 7477. [Abstract] [Full Text] [PDF]

				M. D. Bacolod, S. P. Johnson, A. E. Pegg, M. E. Dolan, R. C. Moschel, N. S. Bullock, Q. Fang, O. M. Colvin, P. Modrich, D. D. Bigner, et al. Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations Mol. Cancer Ther., September 1, 2004; 3(9): 1127 - 1135. [Abstract] [Full Text] [PDF]

				N. J. Curtin, L.-Z. Wang, A. Yiakouvaki, S. Kyle, C. A. Arris, S. Canan-Koch, S. E. Webber, B. W. Durkacz, H. A. Calvert, Z. Hostomsky, et al. Novel Poly(ADP-ribose) Polymerase-1 Inhibitor, AG14361, Restores Sensitivity to Temozolomide in Mismatch Repair-Deficient Cells Clin. Cancer Res., February 1, 2004; 10(3): 881 - 889. [Abstract] [Full Text] [PDF]

				S. C. Schold Jr., D. M. Kokkinakis, S. M. Chang, M. S. Berger, K. R. Hess, D. Schiff, H. I. Robins, M. P. Mehta, K. L. Fink, R.L. Davis, et al. O6-Benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas Neuro-oncol, January 1, 2004; 6(1): 28 - 32. [Abstract] [PDF]

				E. L. Kreklau, K. E. Pollok, B. J. Bailey, N. Liu, J. R. Hartwell, D. A. Williams, and L. C. Erickson Hematopoietic expression of O6-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O6-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea Mol. Cancer Ther., December 1, 2003; 2(12): 1321 - 1329. [Abstract] [Full Text] [PDF]

				L. Tentori, C. Leonetti, M. Scarsella, G. d'Amati, M. Vergati, I. Portarena, W. Xu, V. Kalish, G. Zupi, J. Zhang, et al. Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma Clin. Cancer Res., November 1, 2003; 9(14): 5370 - 5379. [Abstract] [Full Text] [PDF]

				K.-Y. Tserng, S. T. Ingalls, E. M. Boczko, T. P. Spiro, X. Li, S. Majka, S. L. Gerson, J. K. V. Willson, and C. L. Hoppel Pharmacokinetics of O6-Benzylguanine (NSC637037) and Its Metabolite, 8-Oxo-O6-Benzylguanine J. Clin. Pharmacol., August 1, 2003; 43(8): 881 - 893. [Abstract] [Full Text] [PDF]

				M. L. Fishel, S. M. Delaney, L. D. Friesen, R. J. Hansen, E. G. Zuhowski, R. C. Moschel, M. J. Egorin, and M. E. Dolan Enhancement of Platinum-induced Cytotoxicity by O6-Benzylguanine Mol. Cancer Ther., July 1, 2003; 2(7): 633 - 640. [Abstract] [Full Text] [PDF]

				G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibanez Koref Variability and regulation of O6-alkylguanine-DNA alkyltransferase Carcinogenesis, April 1, 2003; 24(4): 625 - 635. [Abstract] [Full Text] [PDF]

				R. Pepponi, G. Marra, M. P. Fuggetta, S. Falcinelli, E. Pagani, E. Bonmassar, J. Jiricny, and S. D'Atri The Effect of O6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 661 - 668. [Abstract] [Full Text] [PDF]

				L. Tentori, I. Portarena, M. Barbarino, A. Balduzzi, L. Levati, M. Vergati, A. Biroccio, B. Gold, M. L. Lombardi, and G. Graziani Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor Mol. Pharmacol., January 1, 2003; 63(1): 192 - 202. [Abstract] [Full Text] [PDF]

				L. Liu, Y. Nakatsuru, and S. L. Gerson Base Excision Repair as a Therapeutic Target in Colon Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2985 - 2991. [Abstract] [Full Text] [PDF]

				M. E. Dolan, M. Posner, T. Karrison, J. Radosta, G. Steinberg, D. Bertucci, L. Vujasin, and M. J. Ratain Determination of the Optimal Modulatory Dose of O6-Benzylguanine in Patients with Surgically Resectable Tumors Clin. Cancer Res., August 1, 2002; 8(8): 2519 - 2523. [Abstract] [Full Text] [PDF]

				M. D. Bacolod, S. P. Johnson, F. Ali-Osman, P. Modrich, N. S. Bullock, O. M. Colvin, D. D. Bigner, and H. S. Friedman Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma Mol. Cancer Ther., July 1, 2002; 1(9): 727 - 736. [Abstract] [Full Text] [PDF]

				L. Liu, S. Schwartz, B. M. Davis, and S. L. Gerson Chemotherapy-induced O6-Benzylguanine-resistant Alkyltransferase Mutations in Mismatch-deficient Colon Cancer Cancer Res., June 1, 2002; 62(11): 3070 - 3076. [Abstract] [Full Text] [PDF]

				L. Tentori, C. Leonetti, M. Scarsella, G. d'Amati, I. Portarena, G. Zupi, E. Bonmassar, and G. Graziani Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site Blood, March 15, 2002; 99(6): 2241 - 2244. [Abstract] [Full Text] [PDF]

				M. Esteller, G. Gaidano, S. N. Goodman, V. Zagonel, D. Capello, B. Botto, D. Rossi, A. Gloghini, U. Vitolo, A. Carbone, et al. Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma J Natl Cancer Inst, January 2, 2002; 94(1): 26 - 32. [Abstract] [Full Text] [PDF]

				L. Long and M. E. Dolan Role of Cytochrome P450 Isoenzymes in Metabolism of O6-Benzylguanine: Implications for Dacarbazine Activation Clin. Cancer Res., December 1, 2001; 7(12): 4239 - 4244. [Abstract] [Full Text] [PDF]

				Y. Cai, S. M. Ludeman, L. R. Wilson, A. B. Chung, and M. E. Dolan Effect of O6-Benzylguanine on Nitrogen Mustard-induced Toxicity, Apoptosis, and Mutagenicity in Chinese Hamster Ovary Cells Mol. Cancer Ther., November 1, 2001; 1(1): 21 - 28. [Abstract] [Full Text] [PDF]

				W. J. Bodell, D. D. Giannini, S. Hassenbusch, and V. A. Levin Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors Neuro-oncol, October 1, 2001; 3(4): 241 - 245. [Abstract] [PDF]

				S. Gururangan, I. Cokgor, J. N. Rich, S. Edwards, M. L. Affronti, J. A. Quinn, J. E. Herndon II, J. M. Provenzale, R. E. McLendon, S. Tourt-Uhlig, et al. Phase I study of GliadelTM wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas Neuro-oncol, October 1, 2001; 3(4): 246 - 250. [Abstract] [PDF]

				D. M. Noll and N. D. Clarke Covalent capture of a human O6-alkylguanine alkyltransferase-DNA complex using N1,O6-ethanoxanthosine, a mechanism-based crosslinker Nucleic Acids Res., October 1, 2001; 29(19): 4025 - 4034. [Abstract] [Full Text] [PDF]

				M. Nakamura, T. Watanabe, Y. Yonekawa, P. Kleihues, and H. Ohgaki Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C {->} A:T mutations of the TP53 tumor suppressor gene Carcinogenesis, October 1, 2001; 22(10): 1715 - 1719. [Abstract] [Full Text] [PDF]

				L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis Cancer Res., August 1, 2001; 61(15): 5757 - 5763. [Abstract] [Full Text] [PDF]

				L. Liu, T. P. Spiro, X. Qin, S. Majka, J. Haaga, J. Schupp, J. K. V. Willson, and S. L. Gerson Differential Degradation Rates of Inactivated Alkyltransferase in Blood Mononuclear Cells and Tumors of Patients after Treatment with O6-Benzylguanine Clin. Cancer Res., August 1, 2001; 7(8): 2318 - 2324. [Abstract] [Full Text] [PDF]

				D. M. Kokkinakis, R. M. Hoffman, E. P. Frenkel, J. B. Wick, Q. Han, M. Xu, Y. Tan, and S. C. Schold Synergy between Methionine Stress and Chemotherapy in the Treatment of Brain Tumor Xenografts in Athymic Mice Cancer Res., May 1, 2001; 61(10): 4017 - 4023. [Abstract] [Full Text]

				K. S. Srivenugopal, J. Shou, S. R. S. Mullapudi, F. F. Lang Jr., J. S. Rao, and F. Ali-Osman Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents Clin. Cancer Res., May 1, 2001; 7(5): 1398 - 1409. [Abstract] [Full Text]

				A. E. Pegg, K. Goodtzova, N. A. Loktionova, S. Kanugula, G. T. Pauly, and R. C. Moschel Inactivation of Human O6-Alkylguanine-DNA Alkyltransferase by Modified Oligodeoxyribonucleotides Containing O6-Benzylguanine J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 958 - 965. [Abstract] [Full Text]

				D. M. Kokkinakis, D. B. Bocangel, S. C. Schold, R. C. Moschel, and A. E. Pegg Thresholds of O6-Alkylguanine-DNA Alkyltransferase which Confer Significant Resistance of Human Glial Tumor Xenografts to Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea or Temozolomide Clin. Cancer Res., February 1, 2001; 7(2): 421 - 428. [Abstract] [Full Text]

				P. Pourquier, J. L. Waltman, Y. Urasaki, N. A. Loktionova, A. E. Pegg, J. L. Nitiss, and Y. Pommier Topoisomerase I-mediated Cytotoxicity of N-Methyl-N'-nitro-N-nitrosoguanidine: Trapping of Topoisomerase I by the O6-Methylguanine Cancer Res., January 1, 2001; 61(1): 53 - 58. [Abstract] [Full Text]

				M. Esteller, J. Garcia-Foncillas, E. Andion, S. N. Goodman, O. F. Hidalgo, V. Vanaclocha, S. B. Baylin, and J. G. Herman Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents N. Engl. J. Med., November 9, 2000; 343(19): 1350 - 1354. [Abstract] [Full Text] [PDF]

				L. Haracska, S. Prakash, and L. Prakash Replication past O6-Methylguanine by Yeast and Human DNA Polymerase eta Mol. Cell. Biol., November 1, 2000; 20(21): 8001 - 8007. [Abstract] [Full Text]

				Y. Cai, M. H. Wu, M. Xu-Welliver, A. E. Pegg, S. M. Ludeman, and M. E. Dolan Effect of O6-Benzylguanine on Alkylating Agent-induced Toxicity and Mutagenicity in Chinese Hamster Ovary Cells Expressing Wild-Type and Mutant O6-Alkylguanine-DNA Alkyltransferases Cancer Res., October 1, 2000; 60(19): 5464 - 5469. [Abstract] [Full Text]

				S. D'Atri, G. Graziani, P. M. Lacal, V. Nisticò, S. Gilberti, I. Faraoni, A. J. Watson, E. Bonmassar, and G. P. Margison Attenuation of O6-Methylguanine-DNA Methyltransferase Activity and mRNA Levels by Cisplatin and Temozolomide in Jurkat Cells J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 664 - 671. [Abstract] [Full Text]

				H. S. Friedman Can O6-Alkylguanine-DNA Alkyltransferase Depletion Enhance Alkylator Activity in the Clinic? Clin. Cancer Res., August 1, 2000; 6(8): 2967 - 2968. [Full Text]

				H. S. Friedman, T. Kerby, and H. Calvert Temozolomide and Treatment of Malignant Glioma Clin. Cancer Res., July 1, 2000; 6(7): 2585 - 2597. [Abstract] [Full Text]

				N. J. Toft, O. J. Sansom, R. A. Brookes, M. J. Arends, M. Wood, G. P. Margison, D. J. Winton, and A. R. Clarke In vivo administration of O6-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine Carcinogenesis, April 1, 2000; 21(4): 593 - 598. [Abstract] [Full Text] [PDF]

				J. E. A. Wibley, A. E. Pegg, and P. C. E. Moody Crystal structure of the human O6-alkylguanine-DNA alkyltransferase Nucleic Acids Res., January 15, 2000; 28(2): 393 - 401. [Abstract] [Full Text] [PDF]

				K. S. Srivenugopal, S. R. S. Mullapudi, J. Shou, T. K. Hazra, and F. Ali-Osman Protein Phosphorylation Is a Regulatory Mechanism for O6-Alkylguanine-DNA Alkyltransferase in Human Brain Tumor Cells Cancer Res., January 1, 2000; 60(2): 282 - 287. [Abstract] [Full Text]

				E. Alvino, R. Pepponi, E. Pagani, P. M. Lacal, C. Nunziata, E. Bonmassar, and S. D'Atri O6-Benzylguanine Enhances the In Vitro Immunotoxic Activity of Temozolomide on Natural or Antigen-Dependent Immunity J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1292 - 1300. [Abstract] [Full Text]

				R. K. Wali, S. Skarosi, J. Hart, Y. Zhang, M.e. Dolan, R. C. Moschel, L. Nguyen, R. Mustafi, T. A. Brasitus, and M. Bissonnette Inhibition of O6-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats Carcinogenesis, December 1, 1999; 20(12): 2355 - 2360. [Abstract] [Full Text] [PDF]

				R. Maze, C. Kurpad, A. E. Pegg, L. C. Erickson, and D. A. Williams Retroviral-Mediated Expression of the P140A, but not P140A/G156A, Mutant Form of O6-Methylguanine DNA Methyltransferase Protects Hematopoietic Cells against O6-Benzylguanine Sensitization to Chloroethylnitrosourea Treatment J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1467 - 1474. [Abstract] [Full Text]

				M. Eileen Dolan, B. L. McRae, E. Ferries-Rowe, M. Belanich, G. A. van Seventer, J. Guitart, D. Pezen, T. M. Kuzel, and D. B. Yarosh O6-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma: Implications for Treatment with Alkylating Agents Clin. Cancer Res., August 1, 1999; 5(8): 2059 - 2064. [Abstract] [Full Text] [PDF]

				M. Xu-Welliver, J. Leitao, S. Kanugula, and A. E. Pegg Alteration of the Conserved Residue Tyrosine-158 to Histidine Renders Human O6-Alkylguanine-DNA Alkyltransferase Insensitive to the Inhibitor O6-Benzylguanine Cancer Res., April 1, 1999; 59(7): 1514 - 1519. [Abstract] [Full Text] [PDF]

				A. E. Pegg, S. Kanugula, S. Edara, G. T. Pauly, R. C. Moschel, and K. Goodtzova Reaction of O6-Benzylguanine-resistant Mutants of Human O6-Alkylguanine-DNA Alkyltransferase with O6-Benzylguanine in Oligodeoxyribonucleotides J. Biol. Chem., May 1, 1998; 273(18): 10863 - 10867. [Abstract] [Full Text] [PDF]